Evidence map›Paper›PMID 27142248›Full record

ArticleNature communications2016

TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesis.

Sayaka Aizawa, Toru Okamoto, Yukari Sugiyama, Takahisa Kouwaki, Ayano Ito, Tatsuya Suzuki, Chikako Ono, Takasuke Fukuhara, Masahiro Yamamoto, Masayasu Okochi and 9 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  11. Article
  12. Article
  13. Physiological functions of SPP/SPPL intramembrane proteases.Cellular and molecular life sciences : CMLS · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Sayaka AizawaDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Toru OkamotoDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Yukari SugiyamaDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Takahisa KouwakiDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Ayano ItoDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Tatsuya SuzukiDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Chikako OnoDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Takasuke FukuharaDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Masahiro YamamotoDepartment of Immunoparasitology, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Masayasu OkochiNeuropsychiatry and Neurochemistry, Department of Integrated Medicine, Osaka University, Osaka 565-0871, Japan.
Nobuhiko HiragaDepartment of Medicine and Molecular Science, Hiroshima University School of Medicine, Hiroshima 734-8551, Japan.
Michio ImamuraDepartment of Medicine and Molecular Science, Hiroshima University School of Medicine, Hiroshima 734-8551, Japan.
Kazuaki ChayamaDepartment of Medicine and Molecular Science, Hiroshima University School of Medicine, Hiroshima 734-8551, Japan.
Ryosuke SuzukiDepartment of Virology II, National Institute of Infectious Diseases, Tokyo 162-8640, Japan.
Ikuo ShojiDivision of Infectious Diseases Control, Center for Infectious Diseases, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
Kohji MoriishiDepartment of Microbiology, Faculty of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
Kyoji MoriyaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Kazuhiko KoikeDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, Japan.
Yoshiharu MatsuuraDepartment of Molecular Virology, Osaka University, Osaka, 565-0871 Japan.
Osaka University · JPHiroshima University · JPThe University of Tokyo · JPKobe University · JPNational Institute of Infectious Diseases · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Signal-peptide peptidase (SPP) is an intramembrane protease that participates in the production of the mature core protein of hepatitis C virus (HCV). Here we show that SPP inhibition reduces the production of infectious HCV particles and pathogenesis. The immature core protein produced in SPP-knockout cells or by treatment with an SPP inhibitor is quickly degraded by the ubiquitin-proteasome pathway. Oral administration of the SPP inhibitor to transgenic mice expressing HCV core protein (CoreTg) reduces the expression of core protein and ameliorates insulin resistance and liver steatosis. Moreover, the haploinsufficiency of SPP in CoreTg has similar effects. TRC8, an E3 ubiquitin ligase, is required for the degradation of the immature core protein. The expression of the HCV core protein alters endoplasmic reticulum (ER) distribution and induces ER stress in SPP/TRC8 double-knockout cells. These data suggest that HCV utilizes SPP cleavage to circumvent the induction of ER stress in host cells.

Indexed as

Host-Pathogen InteractionsVirus ReplicationAnimalsAspartic Acid EndopeptidasesDisease Models, AnimalEndoplasmic Reticulum StressFatty LiverGene Expression RegulationHaploinsufficiencyHepacivirusHepatitis CHumansInsulin ResistanceMaleMiceMice, TransgenicAspartic Acid Endopeptidasesnucleocapsid protein, Hepatitis C virusProteasome Endopeptidase Complexsignal peptide peptidaseUbiquitinUbiquitin-Protein LigasesViral Core Proteins

Identifiers

PMID27142248
PMCPMC4857398
OpenAlexW2347194041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.